Lipocine Inc. (LPCN)

Lipocine Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-16.35	-10.76	-0.63	-20.96	-13.01
Depreciation & Amortization	0.03	0.01	0	0	0.02
Share-Based Compensation	0.65	0.64	0.6	1.37	1.04
Other Operating Activities	3.8	-1.86	-4.38	4.28	0.29
Operating Cash Flow	-11.87	-11.97	-4.41	-15.3	-11.67
Capital Expenditures	-0.01	-0.13	-0.01	0	0
Change in Investments	13.1	14.43	-43.77	3.89	3
Investing Cash Flow	13.08	14.29	-43.78	3.89	3
Share Issuance / Repurchase	0.4	0.19	30.26	22.33	13.65
Debt Issued / Paid	0	-2.32	-3.33	-1.43	-3.33
Financing Cash Flow	0.4	-2.13	26.92	20.9	10.32
Net Cash Flow	1.62	0.2	-21.27	9.49	1.65
Free Cash Flow	-11.88	-12.1	-4.42	-15.3	-11.67
Free Cash Flow Margin	-	-2420.53%	-27.38%	-	-7070.86%
Free Cash Flow Per Share	-2.25	-2.31	-0.86	-4.67	-7.66

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).